Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Advisory Committees

-

Slides for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

Morning Session

FDA

FDA Presentations, Votrient (pazopanib) tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 324KB)

GlaxoSmithKline

GSK Presentations, Votrient (pazopanib) tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.74MB)

Afternoon Session

FDA

FDA Main Presentations, Taltorvic (ridaforolimus) tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 402KB)

FDA Backup Presentations, Taltorvic (ridaforolimus) tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 27KB)

Merck Sharp & Dohme Corp.

Merck Main Presentations, Taltorvic (ridaforolimus) tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 276KB)

Merck Backup Presentations, Taltorvic (ridaforolimus) tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 147KB)

-

-